FDA Inspection 1193124 — Mi Gwang Contact Lens Co., Ltd.

Mi Gwang Contact Lens Co., Ltd. — FEI 3003499948

The FDA completed an inspection of Mi Gwang Contact Lens Co., Ltd. on December 15, 2022 in Gyeongsan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 6 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 15, 2022
Fiscal Year
2023
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Gyeongsan (Korea (the Republic of))

Citations

IDCFRDescription
2142421 CFR 820.120(b)Labeling inspection - UDI
243021 CFR 820.30(b)Design plans - Lack of or inadequate
310321 CFR 820.30(i)Design changes - Lack of or Inadequate Procedures
311121 CFR 820.70(f)Buildings
315921 CFR 820.184DHR content
328221 CFR 820.90(a)Nonconforming product, Lack of or inadequate procedures